论文部分内容阅读
糖尿病肾病是糖尿病最常见的慢性并发症之一,国内发病率达20%左右。如何有效防止糖尿病肾病的发生发展已受到临床广泛关注,目前尚无特效治疗方法。怡开为微循环障碍改善剂,近年来投入临床治疗糖尿病并发症,有良好而广泛的使用范围,我们观察怡开及对照组治疗糖尿病早期肾病36例,
Diabetic nephropathy is one of the most common chronic complications of diabetes, with a domestic incidence of about 20%. How to effectively prevent the occurrence and development of diabetic nephropathy has received widespread clinical attention, there is no effective treatment. Yue Kai as a microcirculation improvement agent, put into clinical treatment of diabetic complications in recent years, there is a good and wide range of use, we observed Yi Kai and the control group of 36 cases of early diabetic nephropathy,